Evidence map›Paper›PMID 33994616›Full record

ArticleMedicina intensiva2021

[Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].

Á Estella, P Vidal-Cortés, A Rodríguez, D Andaluz Ojeda, I Martín-Loeches, E Díaz, B Suberviola, M P Gracia Arnillas, M Catalán González, F Álvarez-Lerma and 4 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina intensiva, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 19 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Á EstellaServicio de Medicina Intensiva, Hospital Universitario de Jerez, Departamento de Medicina, Facultad de Medicina de Cádiz, Jerez de la Frontera, Cádiz, España.
P Vidal-CortésServicio de Medicina Intensiva, Complexo Hospitalario Universitario de Ourense, Ourense, España.
A RodríguezServicio de Medicina Intensiva, Hospital Universitario Joan XXIII de Tarragona, Tarragona, España.
D Andaluz OjedaServicio de Medicina Intensiva, Hospital Universitario de Sanchinarro de Madrid, Madrid, España.
I Martín-LoechesPhD JFICMI Consultant in Intensive Care Medicine, CLOD Dublin Midlands group, St James's University Hospital, Trinity Centre for Health Sciences, HRB-Welcome Trust St James's Hospital, Dublín, EIRE, Universidad de Barcelona, Barcelona, España.
E DíazServicio de Medicina Intensiva, Hospital Parc Tauli, Sabadell, España.
B SuberviolaServicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla. Santander, España.
M P Gracia ArnillasServicio de Medicina Intensiva, Hospital Universitario del Mar, Barcelona, España.
M Catalán GonzálezServicio de Medicina Intensiva, Hospital Universitario 12 de Octubre, Madrid, España.
F Álvarez-LermaServicio de Medicina Intensiva, Parc de Salut Mar, Hospital del Mar, Barcelona, España.
P RamírezServicio de Medicina Intensiva, Hospital La Fe de Valencia, Valencia, España.
X NuvialsServicio de Medicina Intensiva, Hospital Vall d'Hebrón, Barcelona, España.
M BorgesUnidad Multidisciplinar de Sepsis, Servicio de Medicina Intensiva, Hospital Universitario Son Llatzer, IDISBA, Enfermedades Infecciosas UIB, Palma de Mallorca, Área de Sepsis e Infecciosas, Federación Ibérica y Panamericana de Medicina Intensiva (FEPIMCTI), Palma de Mallorca, España.
R ZaragozaServicio de Medicina Intensiva, Hospital Universitario Dr. Peset, Valencia, España.
Complexo Hospitalario Universitario A Coruña · ESDeleted InstitutionHospital Del Mar · ESHospital Jerez Puerta del Sur · ESHospital Universitari Joan XXIII de Tarragona · ESHospital Universitario 12 De Octubre · ESHospital Universitario Doctor Peset · ESHospital Universitario HM Sanchinarro · ESInstituto de Investigación Sanitaria La Fe · ESMarqués de Valdecilla University Hospital · ESParc de Salut · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections have become one of the main complications of patients with severe SARS-CoV-2 pneumonia admitted in ICU. Poor immune status, frequent development of organic failure requiring invasive supportive treatments, and prolonged ICU length of stay in saturated structural areas of patients are risk factors for infection development. The Working Group on Infectious Diseases and Sepsis GTEIS of the Spanish Society of Intensive Medicine and Coronary Units SEMICYUC emphasizes the importance of infection prevention measures related to health care, the detection and early treatment of major infections in the patient with SARS-CoV-2 infections. Bacterial co-infection, respiratory infections related to mechanical ventilation, catheter-related bacteremia, device-associated urinary tract infection and opportunistic infections are review in the document.

Indexed as

Infection preventionNosocomialOpportunistic infectionsPneumoniaSARS-CoV-2

Identifiers

PMID33994616
PMCPMC8086823
OpenAlexW3197270055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.